Welcome to Ascendia Pharmaceuticals
We are a specialty CDMO with a suite of nanotechnology platforms, dedicated to providing
CDMO services to enable pre-clinical and clinical stage formulations and to developing a 505(b)(2) pipeline of enhanced versions of existing drug products for our clients. We specialize in improving the bioavailability and drug delivery of poorly water
soluble drugs using our nano-particle and controlled release
technologies.
